Showing results (51-60 of 87) with videos related to
Sort By:
Pageof 9
Transplantation|February 20, 2016
The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot StudyBenjamin L Laskin, Harsharan K Singh, Ulf H Beier, et al.Cell Reports|December 16, 2020
Lactate Limits T Cell Proliferation via the NAD(H) Redox StateWilliam J Quinn, Jing Jiao, Tara TeSlaa, et al.Antimicrobial Agents and Chemotherapy|April 5, 2017
Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure InfectionsWilliam O'Riordan, Courtney Tiffany, Nicole Scangarella-Oman, et al.Journal of Digestive Diseases|April 24, 2020
The use of combination biological or small molecule therapy in inflammatory bowel disease: A retrospective cohort studyKerri Glassner, Ayah Oglat, Antonio Duran, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 11, 2014
Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG StudyBorje Darpo, Meijian Zhou, Jessica Matthews, et al.International Journal of Cancer|December 26, 2015
HDAC5 controls the functions of Foxp3(+) T-regulatory and CD8(+) T cellsHaiyan Xiao, Jing Jiao, Liqing Wang, et al.Diabetologia|September 12, 2014
HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylureaPeter N Weissman, Molly C Carr, June Ye, et al.Diabetes Care|June 6, 2014
HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metforminBo Ahrén, Susan L Johnson, Murray Stewart, et al.JCI Insight|August 18, 2017
Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factorsTatiana Akimova, Tianyi Zhang, Dmitri Negorev, et al.Journal of Digestive Diseases|April 10, 2024
Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumabMohammed Ansari, Kerri Glassner, Malcolm Irani, et al.Pageof 9